No Data
10-Q: Q2 2024 Earnings Report
10-Q: Q1 2024 Earnings Report
Bowen Acquisition Corp Announces Merger Details in Press Release
Health products company “Qianzhi Biotechnology” plans to go public in the US under the cover of SPAC
Qianzhi Group Holding (Cayman) Limited, the holding company of Shenzhen Qianzhi Biotechnology Co., Ltd., Shenzhen Qianzhi Biotechnology Co., Ltd. from Shenzhen, Guangdong, signed a merger agreement with SPAC (US special purpose acquisition company) Bowen Acquisition Corp (BOWN) to be listed on the US NASDAQ through a backshell SPAC.
Bowen Acquisition Agrees to Merge With Shenzhen Qianzhi BioTechnology
Trading Halt: Halt Status Updated at 6:55:00 AM ET: Quotation Resumption: News and Resumption Times
No Data
No Data